Control group | Group 1: mild disease | Group 2: moderate disease | Group 3: severe disease | Significance among all groups | ||
Superficial central VD | Mean | 16.1432 | 17.416 | 13.411 | 12.968 | 0.002* |
SD | 3.405 | 4.079 | 4.793 | 3.566 | ||
Superficial inferior VD | Mean | 50.368 | 50.125 | 52.980 | 50.464 | 0.761* |
SD | 2.712 | 3.321 | 8.293 | 2.483 | ||
Superficial superior VD | Mean | 49.995 | 49.013 | 50.128 | 50.141 | 0.391† |
SD | 2.406 | 2.053 | 2.376 | 2.666 | ||
Superficial nasal VD | Mean | 43.373 | 42.716 | 44.530 | 44.340 | 0.163† |
SD | 2.302 | 3.496 | 2.694 | 2.485 | ||
Superficial temporal VD | Mean | 47.711 | 46.015 | 49.925 | 48.271 | <0.001† |
SD | 2.369 | 3.461 | 2.602 | 2.307 | ||
Image quality | Mean | 63.42 | 63.44 | 61.950 | 64.120 | 0.452† |
SD | 3.220 | 5.044 | 5.162 | 3.100 | ||
FAZ area | Mean | 0.223 | 0.210 | 0.411 | 0.343 | <0.001† |
SD | 0.150 | 0.017 | 0.022 | 0.026 | ||
Deep central VD | Mean | 15.495 | 15.782 | 12.430 | 11.388 | 0.002* |
SD | 4.613 | 4.068 | 5.382 | 3.933 | ||
Deep inferior VD | Mean | 51.507 | 53.223 | 53.324 | 52.645 | 0.7347* |
SD | 5.327 | 3.974 | 3.809 | 3.218 | ||
Deep superior VD | Mean | 51.066 | 50.996 | 52.466 | 51.361 | 0.484† |
SD | 3.606 | 3.167 | 3.451 | 3.175 | ||
Deep nasal VD | Mean | 49.497 | 46.551 | 50.707 | 49.419 | 0.010† |
SD | 3.693 | 3.021 | 4.499 | 3.650 | ||
Deep temporal VD | Mean | 48.034 | 48.430 | 50.092 | 47.708 | 0.043* |
SD | 2.898 | 2.893 | 3.027 | 2.769 |
Significant values shown in bold.
*H Kruskal-Wallis.
†ANOVA test.
ANOVA, analysis of variance; FAZ, foveal avascular zone; VD, vessel density.